The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.

[1]  J Zhang,et al.  2019 global NAFLD prevalence - A systematic review and meta-analysis. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  A. Thrift,et al.  Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017–2018 , 2021, PloS one.

[3]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[4]  E. Cholongitas,et al.  Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis , 2021, Annals of gastroenterology.

[5]  Shenmin Zhang,et al.  Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity , 2021, Scandinavian journal of gastroenterology.

[6]  E. Tsochatzis,et al.  Case-finding strategies in non-alcoholic fatty liver disease , 2020, JHEP reports : innovation in hepatology.

[7]  A. Cantoral,et al.  Review: Type 2 diabetes in Latin America and the Caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention. , 2020, Primary care diabetes.

[8]  Hwi-Young Kim,et al.  Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease , 2020, Scientific Reports.

[9]  S. Reeder,et al.  Liver fat quantification: where do we stand? , 2020, Abdominal Radiology.

[10]  H. Shatat,et al.  Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting. , 2020, The American journal of the medical sciences.

[11]  Takanori Ito,et al.  Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis , 2020, Scientific Reports.

[12]  M. Swain,et al.  Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer? , 2019, Nutrients.

[13]  J. Lee,et al.  Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults. , 2019, Metabolism: clinical and experimental.

[14]  A. Farcomeni,et al.  Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation. , 2019, Mayo Clinic proceedings.

[15]  M. Fukui,et al.  The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study , 2019, Canadian journal of gastroenterology & hepatology.

[16]  Hongliang Li,et al.  Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis , 2019, Hepatology.

[17]  A. Suzuki,et al.  Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps , 2019, Hepatology.

[18]  S. Wild,et al.  Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study , 2019, Journal of clinical medicine.

[19]  V. Wong,et al.  Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. , 2019, The lancet. Gastroenterology & hepatology.

[20]  A. Motala,et al.  Non-alcoholic fatty liver disease in Africa: a hidden danger , 2019, Global health, epidemiology and genomics.

[21]  M. Fukui,et al.  Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study. , 2019, Journal of gastrointestinal and liver diseases : JGLD.

[22]  Z. Younossi.  Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.

[23]  Yoosoo Chang,et al.  Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study , 2018, Journal of clinical medicine.

[24]  S. Buscemi,et al.  Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[25]  Kun Wang,et al.  Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study , 2018, Lipids in Health and Disease.

[26]  Rohit Loomba,et al.  Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials , 2018, Hepatology.

[27]  Y. Hiasa,et al.  Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study , 2018, PloS one.

[28]  D. S̆timac,et al.  Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? , 2018, World journal of gastroenterology.

[29]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[30]  M. A. Khan,et al.  Clinical epidemiology and disease burden of nonalcoholic fatty liver disease , 2017, World journal of gastroenterology.

[31]  A. Lonardo,et al.  Nonalcoholic fatty liver disease: Evolving paradigms , 2017, World journal of gastroenterology.

[32]  Yingli Lu,et al.  Blood lead level is associated with non-alcoholic fatty liver disease in the Yangtze River Delta region of China in the context of rapid urbanization , 2017, Environmental Health.

[33]  Youming Li,et al.  Serum apoB levels independently predict the development of non‐alcoholic fatty liver disease: A 7‐year prospective study , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[34]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[35]  K. Humphreys,et al.  Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. , 2016, Addiction.

[36]  European Association for the Study of the Liver,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease , 2016, Obesity Facts.

[37]  C. Tufanaru,et al.  Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data , 2015, International journal of evidence-based healthcare.

[38]  M. Braddock,et al.  Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease , 2015, Medicine.

[39]  V. Wong,et al.  Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. , 2015, Journal of hepatology.

[40]  F. Nascimbeni,et al.  Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease , 2014, Alimentary pharmacology & therapeutics.

[41]  H. Keyvani,et al.  Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran , 2014, Iranian journal of public health.

[42]  A. Sutton,et al.  In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. , 2014, Journal of clinical epidemiology.

[43]  Z. Halpern,et al.  Non‐high‐density lipoprotein cholesterol independently predicts new onset of non‐alcoholic fatty liver disease , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[44]  H. J. Yoo,et al.  Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[45]  S. Barakat,et al.  Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors? , 2014, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[46]  M. Rovers,et al.  The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[47]  Eliseo Guallar,et al.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. , 2013, American journal of epidemiology.

[48]  T. Therneau,et al.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States , 2013, Hepatology.

[49]  Sun Guang-hui.  Relationship between components of metabolic syndrome and incidence of non-alcoholic fatty liver disease , 2012 .

[50]  Eliseo Guallar,et al.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.

[51]  C. Onyekwere,et al.  Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. , 2011, Annals of hepatology.

[52]  P. López-Jaramillo,et al.  Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. , 2011, Preventive medicine.

[53]  Stephen R Cole,et al.  Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.

[54]  O. Nóbrega,et al.  Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. , 2007, Sao Paulo medical journal = Revista paulista de medicina.

[55]  M. Kew,et al.  Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[56]  T. Omatsu,et al.  The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease , 2006, Annals of Internal Medicine.